+33 64 94 75 259
First and foremost, i3 Consult hopes that you and your loved ones are healthy and safe.
In this press release, we want to reiterate that i3 Consult is both open for business and, like you, working remotely to help flatten the curve.
We are implementing innovative strategies to address the challenges of COVID-19 to ensure the continuity of our research and reporting on clinical trials programmes, collaboration with our healthcare, pharmaceutical and life science partners to minimise disruptions and delays. Toward this initiative all our reporting on clinical trials ongoing is being posted on our Clinical Trial Report page, click here for a glimpse of what has been reported most recently on the COVID-19 clinical trials.